Gene · 7112
Papers1,529
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,529
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Coatomer in the universe of cellular complexity. | Mol Biol Cell | 2022 | 36399624 | PubTator, text mining | PubMed |
| Recurrent acute myocarditis: An under-recognized clinical entity associated with the later diagnosis of a genetic arrhythmogenic cardiomyopathy. | Front Cardiovasc Med | 2022 | 36386348 | PubTator, text mining | PubMed |
| ARPC1B promotes mesenchymal phenotype maintenance and radiotherapy resistance by blocking TRIM21-mediated degradation of IFI16 and HuR in glioma stem cells. | J Exp Clin Cancer Res | 2022 | 36380368 | PubTator, text mining | PubMed |
Leukocyte Nuclear Morphology Alterations in Dilated Cardiomyopathy Caused by a Lamin AC Truncating Mutation (LMNA/Ser431*) Are Modified by the Presence of a LAP2 Missense Polymorphism (TMPO/Arg690Cys). | Int J Mol Sci | 2022 | 36362411 | PubTator, text mining | PubMed |
| Loss of the Nuclear Envelope Protein LAP1B Disrupts the Myogenic Differentiation of Patient-Derived Fibroblasts. | Int J Mol Sci | 2022 | 36362402 | PubTator, text mining | PubMed |
| Intersection of the Orphan G Protein-Coupled Receptor, GPR19, with the Aging Process. | Int J Mol Sci | 2022 | 36362387 | PubTator, text mining | PubMed |
| Antiviral Potential of Plants against COVID-19 during Outbreaks-An Update. | Int J Mol Sci | 2022 | 36362351 | PubTator, text mining | PubMed |
| Transgenic force sensors and software to measure force transmission across the mammalian nuclear envelope in vivo. | Biol Open | 2022 | 36350289 | PubTator, text mining | PubMed |
| Nuclear Morphological Abnormalities in Cancer: A Search for Unifying Mechanisms. | Results Probl Cell Differ | 2022 | 36348118 | PubTator, text mining | PubMed |
| Processes in DNA damage response from a whole-cell multi-omics perspective. | iScience | 2022 | 36339253 | PubTator, text mining | PubMed |
| Identification and Validation of a Novel Necroptosis-Related Long Noncoding RNA Prognostic Signature for Lung Adenocarcinoma. | Biomed Res Int | 2022 | 36330457 | PubTator, text mining | PubMed |
| MicroRNA-383: A tumor suppressor miRNA in human cancer. | Front Cell Dev Biol | 2022 | 36313570 | PubTator, text mining | PubMed |
| Lentivirus-mediated short hairpin RNA interference of CENPK inhibits growth of colorectal cancer cells with overexpression of Cullin 4A. | World J Gastroenterol | 2022 | 36312839 | PubTator, text mining | PubMed |
| Epithelial-mesenchymal transition-related long noncoding RNAs in gastric carcinoma. | Front Mol Biosci | 2022 | 36310592 | PubTator, text mining | PubMed |
| Characterization of fatty acid metabolism-related lncRNAs in lung adenocarcinoma identifying potential novel prognostic targets. | Front Genet | 2022 | 36299578 | PubTator, text mining | PubMed |
| Docetaxel-resistant triple-negative breast cancer cell-derived exosomal lncRNA LINC00667 reduces the chemosensitivity of breast cancer cells to docetaxel <em>via</em> targeting miR-200b-3p/Bcl-2 axis. | Eur J Histochem | 2022 | 36281649 | PubTator, text mining | PubMed |
| UBE2O promotes lipid metabolic reprogramming and liver cancer progression by mediating HADHA ubiquitination. | Oncogene | 2022 | 36273042 | PubTator, text mining | PubMed |
| A review on the role of cyclin dependent kinases in cancers. | Cancer Cell Int | 2022 | 36266723 | PubTator, text mining | PubMed |
| Clinical Implication of Genetic Testing in Dilated Cardiomyopathy. | Int J Heart Fail | 2022 | 36262197 | PubTator, text mining | PubMed |
| USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma. | Oncogene | 2022 | 36243803 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7112/papers?page=9